Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Role of NaV1.8 in Human Pain Models
NCT07511400Phase 1Completed
- Sponsor
- Medical University of Vienna
- Start
- Apr 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of suzetrigine in acute pain (3 arms), sponsored by Medical University of Vienna. Primary endpoints: Pain Intensity following Electrical stimulation, Geometric Mean Pain Intensity following Mechanical stimulation and 4 more. Started Apr 2026; status: completed.
02
Drugs
suzetrigine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT07511400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07511400.